- Future Proof PT
- Posts
- MSK Weekly Literature Review
MSK Weekly Literature Review
Weekly Edition | Workforce, Access, Demand & the Population Health Imperative
Synthesizing peer-reviewed evidence for clinicians, health system executives, payers, and clinical leaders.
THIS WEEK: The PT Profession at an Inflection Point -Demand Rises, Access Fractures, and the Workforce Burns Out
Physical therapy sits at the intersection of every major trend reshaping American healthcare: surging procedural demand, persistent access inequities, a workforce in distress, and mounting evidence that population-level prevention is the only mathematically sustainable path forward. This week's five entries examine each of these forces through a peer-reviewed lens -and the picture they assemble together is both urgent and actionable. From GWAS-level genomics last week to arthroplasty demand projections to 2060, the evidence is converging on a single conclusion: the delivery infrastructure for musculoskeletal rehabilitation is not built for the world it is about to face.
MONDAY
Beyond the Treatment Table: Why Physical Therapy Must Become a Public Health Discipline
For: H System Executives | PT Leaders | Payers | Policy Makers | Digital Health Strategists
One in Three People Need Rehabilitation. The System Serves a Fraction of Them.
The scale of the problem is hard to overstate. One in three patients worldwide has a condition that would benefit from rehabilitation services. Musculoskeletal disorders remain the leading cause of disability globally, affecting 1.71 billion people -1 in 2 U.S. adults. Yet the physical therapy profession, in its dominant form, is organized around one-to-one, tertiary, in-person care delivered in clinics that most of the world's population cannot reach, afford, or navigate.
A 2024 article in Physical Therapy by Mckinney, Kelm, Windsor, and Keyser makes the structural diagnosis explicit: physical therapy has historically operated at the top of Frieden's Health Impact Pyramid -the most resource-intensive, least scalable tier of intervention. If the profession does not descend that pyramid into primary prevention, community health, and population-level programming, it will remain structurally incapable of reducing the burden it claims to address.
This is not a critique of individual clinicians. It is an indictment of a delivery model that has never been designed for scale.
"Relying on highly individualized and in-person care… will continue to leave too many people behind." -Mckinney et al., 2024, Physical Therapy
The Framework: Applying Public Health Logic to PT Practice
Frieden's Pyramid as a Strategic Map
The authors use Frieden's Health Impact Pyramid to argue that PT's greatest untapped leverage is at the lower tiers: socioeconomic interventions, changing the context to make healthy defaults easier, and clinical-community linkages -not just direct one-on-one care. They are explicit that "there is opportunity to apply a physical therapist skill set to the lower levels of this pyramid to affect population health outcomes."
The proposed public health problem-solving model for PT follows a four-step iterative framework:
Surveillance -identify who is not receiving care and why, mapped at population and community level
Risk and protective factor analysis -understand which modifiable upstream determinants drive MSK burden
Develop and evaluate interventions -build and test scalable, community-integrated care models
Implementation and scale -disseminate what works through workforce models, partnerships, and policy
This is not foreign to the PT profession intellectually. It is, however, foreign to most PT business models, reimbursement structures, and training curricula. That gap is the problem.
Digital Health as the Access Multiplier
Telerehabilitation is the authors' primary technology lever. They argue it "may mitigate costs and increase availability of physical therapist services especially in communities that face access challenges." The clinical logic demonstrated that telehealth adoption in rehabilitation was not only possible but preferred by a meaningful segment of patients -and the profession has not yet fully absorbed what that signal means for care model design.
The article highlights a range of scalable digital tools already showing evidence of impact:
Hybrid care models pairing in-person evaluation with remote follow-through
Remote monitoring using wearables and sensors for home exercise adherence
App-based patient education and self-management platforms
Digital therapeutics such as the Leva Pelvic Health System, an FDA-cleared digital PFMT intervention
Task-shifting models in low-resource settings, training community health workers in evidence-based PT protocols
The regulatory environment remains unsettled -a genuine operational constraint the authors acknowledge. But regulatory ambiguity is not a reason to delay capability-building; it is a reason to engage in advocacy and pilot design simultaneously.
Two Use Cases That Illustrate the Potential
The authors develop two clinical use cases with strong evidence bases: musculoskeletal disorders and pelvic floor disorders. The MSK case is familiar to most health system leaders. The PFD case is less so -and more instructive.
PFDs affect one-third of women worldwide. Treatment utilization is extraordinarily low: in one study, less than 3% of patients who had received a PFD diagnosis had documented pelvic floor muscle training or PT visits. This is a condition with strong evidence for non-surgical, PT-led treatment and a near-total failure of delivery. Group-based PFMT, telehealth PFMT, and community task-shifting programs in Nigeria and sub-Saharan Africa demonstrate that scalable, affordable, effective delivery is achievable -where organizations are willing to design for it.
The Operational and Financial Reality
Health systems investing in population-level PT capability face real friction: FFS billing architecture, productivity metrics built around per-visit revenue, and a clinical culture that defines quality primarily through the individual patient encounter. None of these are immovable.
Employer-direct contracting models, value-based bundles for MSK conditions, and risk-bearing primary care partnerships are already creating alternative incentive structures that reward population-level outcomes rather than procedure volume. PT practices and health systems positioned as MSK population health partners -rather than downstream referral destinations -are building a different and more durable market position.
The Takeaway
Health systems that treat physical therapy as a volume-dependent ancillary service are building the wrong infrastructure for the coming decade. The evidence supports a fundamentally different organizational posture: PT as a primary prevention resource, a population health partner, and a digital health delivery channel. The clinical science is ahead of the delivery model. Closing that gap is a strategic priority -not a future aspiration.
For executives: where in your care model is PT functioning at the prevention and community level, not just the tertiary level? For payers: what contracting structures incentivize PT-led population health outcomes rather than per-visit utilization? These are the questions the evidence is now demanding.
🌍 Rehabilitation need exceeds capacity -1 in 3 patients worldwide has a condition benefiting from rehabilitation; MSDs affect 1.71 billion people globally.
🧩 Public health framework for PT -Frieden's Pyramid provides a strategic map for shifting PT from tertiary care to population-level prevention and community health.
📱 Digital health as access multiplier -Telerehabilitation, wearables, digital therapeutics, and task-shifting can scale PT services to underserved populations.
💪 MSDs and PFDs as scalable use cases -Both conditions show strong evidence for group, telehealth, and community-based PT models -when organizations design for them.
🚀 Delivery model must evolve -The profession must move toward systems-level innovation, new contracting models, and preventive care to match the scale of the problem.
Mckinney, J., Kelm, N., Windsor, B., & Keyser, L. E. (2024). Addressing health care access disparities through a public health approach to physical therapist practice. Physical Therapy, 104(10), pzae136. https://doi.org/10.1093/ptj/pzae136
TUESDAY
The 42-Point Access Gap: How Insurance Status Determines Who Gets Physical Therapy After Surgery
For: Health System Executives | Payers | Orthopedic Leaders | Equity & Access Officers | PT Network Planners
Same Surgery, Radically Different Recovery -Depending on Your Insurance Card
When a patient undergoes rotator cuff repair, the surgical outcome is only as good as the rehabilitation that follows. Physical therapy is not optional in this context -it is mechanistically required for restoring function, preventing stiffness, and avoiding reoperation. Yet a 2021 national survey study published in JSES International reveals that access to postoperative PT after rotator cuff repair is not distributed equitably. It is distributed almost entirely by insurance type.
Researchers contacted 465 PT clinics nationwide and found a 42-percentage-point access gap: 94.9% of clinics accepted private insurance while only 52.7% accepted Medicaid. This is not a marginal disparity. For a Medicaid-enrolled patient leaving the hospital after rotator cuff repair, there is nearly a coin-flip chance that the nearest PT clinic will not see them at all.
"Overall, 52.7% accepted Medicaid insurance, while 94.9% accepted private insurance." -Curry et al., 2021, JSES International
The Evidence: Structural Barriers, Not Individual Choices
Why Clinics Say No
The study identifies the dominant reason clinics refuse Medicaid patients: lack of a contract with the payer (40.7% of refusals). This is a structural and administrative barrier, not a clinical or capacity decision. It reflects how Medicaid reimbursement rates, contract negotiation complexity, and administrative burden have shaped PT clinic business models over decades -often making Medicaid participation economically untenable for smaller, independent practices.
Other structural barriers documented in the study include:
Low or no payment relative to cost of care delivery
Visit caps imposed by state Medicaid programs (some allowing as few as one evaluation plus three treatment visits post-repair)
Caps on the number of Medicaid patients a practice will accept
Cash-only clinic models that structurally exclude all insurance-dependent patients
Regional Disparities: The South Is the Epicenter
Medicaid acceptance varied dramatically by geography -and the regional pattern maps almost perfectly onto Medicaid expansion decisions:
West: 73.7% Medicaid acceptance | South: 32.3% Medicaid acceptance |
Midwest: 63.6% Medicaid acceptance | Expansion states: 56.1% acceptance |
Northeast: 46.8% Medicaid acceptance | Non-expansion states: 46.3% acceptance (borderline significant, P = .05) |
Even in Medicaid expansion states -where coverage has broadened -the acceptance rate improvement is modest and barely statistically significant. Expanding coverage without addressing reimbursement rates and administrative infrastructure produces only marginal gains in access.
Wait Times: Equal Medians, Unequal Ranges
On the surface, median wait times for first appointments appeared similar -approximately two days for both Medicaid and privately insured patients. But the ranges tell a different story: Medicaid patients faced waits of 0 to 72 days, compared to 0 to 43 days for privately insured patients. For a postoperative patient whose recovery window is time-sensitive, a 72-day delay is not a scheduling inconvenience -it is a clinical risk.
Zip Code as a Proxy for Quality
The study also found that Medicaid-accepting clinics were located in ZIP codes with significantly lower median household incomes ($57,099 vs. $61,481, P = .01). This suggests a geographic concentration of Medicaid-accepting clinics in lower-resource areas -which may limit access to specialized PT services, better-equipped facilities, or clinicians with advanced training in postoperative orthopedic rehabilitation.
The Clinical and Operational Stakes
Inadequate postoperative PT after rotator cuff repair is not a quality-of-life issue alone -it carries measurable clinical consequences: increased risk of stiffness, scar tissue formation, poor patient-reported outcomes, and elevated reoperation rates. For health systems and payers carrying risk for surgical episode outcomes, the failure to secure PT access for Medicaid patients is a financial liability as well as an equity failure.
The authors recommend that surgeons proactively help Medicaid patients secure PT access before discharge -including exploring hospital-based outpatient PT, home exercise programs with structured family support, or community-based alternatives. But this is a workaround, not a solution. The system design problem requires a system design answer.
The Takeaway
For health system executives and orthopedic service line leaders: if your surgical program accepts Medicaid, your post-acute PT network must be designed to match. An integrated care model that performs surgery on a Medicaid patient and then releases them into a fragmented PT access landscape is not a care model -it is a half-finished procedure.
For payers and Medicaid managed care organizations: reimbursement rates and administrative contracting requirements are the primary levers here. Where access is the goal, the rate and contracting structure must reflect it. For network planners and health equity officers: the geographic concentration of Medicaid-accepting PT in lower-income ZIP codes is not a neutral market outcome -it is a signal that network adequacy standards for PT are not functioning.
🟥 42-point access gap -52.7% of PT clinics accept Medicaid vs. 94.9% for private insurance -a structural disparity with direct clinical consequences.
🌎 Regional concentration in the South -The South shows the lowest Medicaid PT acceptance at 32.3%, tracking closely with non-expansion states.
📉 Structural barriers drive refusal -Lack of payer contracts, low reimbursement, and visit caps are the primary systemic drivers -not clinic-level preference.
⏳ Wait time variability is the clinical risk -Medicaid patients face waits up to 72 days vs. 43 for private -unacceptable variability in a time-sensitive postoperative window.
🏥 Zip code predicts access quality -Medicaid-accepting clinics cluster in lower-income areas, compounding access inequity with resource inequity.
Curry, E. J., Penvose, I. R., Knapp, B., Parisien, R. L., & Li, X. (2021). National disparities in access to physical therapy after rotator cuff repair between patients with Medicaid vs. private health insurance. JSES International, 5(4), 507–511. https://doi.org/10.1016/j.jseint.2020.11.006
WEDNESDAY
Half the Profession Is Burned Out -and Mentorship May Be the Most Actionable Fix
For: PT Clinical Leaders | Health System Workforce Officers | Post-Acute & SNF Administrators | Residency Program Directors
Nearly One in Two Physical Therapists Reports Burnout
Workforce sustainability is not a background concern for the rehabilitation profession. It is the defining constraint on everything else this week's evidence calls for -scaling population health programs, expanding Medicaid access, absorbing the coming arthroplasty demand surge. None of that is possible without a functional, retained, engaged PT workforce. And that workforce is, by its own account, in distress.
A 2023 cross-sectional survey study published in the Journal of Educational Evaluation for Health Professions surveyed 2,813 physical therapists across all 50 states and found that "almost half of respondents (49.34%) reported burnout." This was measured using the validated BCSQ-12 instrument and confirmed by strong agreement with a self-report item (rrb = 0.61). Critically, these data were collected during the COVID-19 pandemic -yet burnout rates were comparable to pre-pandemic levels, suggesting the underlying conditions predate the acute disruption.
"Burnout was significantly lower among those who provided formal mentorship... compared to no mentorship." -Pugliese et al., 2023
Where Burnout Is Worst -and Why It Matters for System Design
Setting-Specific Burnout: Post-Acute and Home Health Are the Red Zones
The study identified substantial variation by practice setting. Home health and skilled nursing facility settings showed the highest burnout scores on the BCSQ-12, while school systems, academic settings, and outpatient clinics showed meaningfully lower levels. This is not surprising to anyone with visibility into post-acute PT work conditions: high patient volume, high clinical complexity, significant administrative burden, frequent productivity pressure, and limited peer support or mentorship infrastructure.
For health system leaders managing post-acute networks or SNF partnerships, this finding is operationally significant. The settings with the highest patient acuity and the greatest downstream impact on readmission risk and functional outcomes are also the settings burning through their PT workforce fastest. That is not a sustainable configuration.
Home health: highest burnout scores (median BCSQ-12 = 42.00) | Outpatient clinic: below-median burnout |
Skilled nursing: second highest burnout (median BCSQ-12 = 43.00) | 49.34% of U.S. PTs report burnout |
Academic/school settings: lowest burnout scores | Burnout rate pre-dates COVID -structural, not situational |
What the Data Show Actually Works
The study identifies two variables with consistent, statistically significant protective associations with lower burnout: mentorship and self-efficacy.
On mentorship, the findings are precise. PTs who received formal mentorship showed meaningfully lower burnout scores than those with no mentorship (median BCSQ-12: 38.00 vs. 41.00). PTs who provided formal mentorship also showed lower burnout than those who provided none (39.00 vs. 41.00). Both directions of the mentorship relationship -receiving and giving -are protective. This is an important nuance: mentorship is not only a resource for junior clinicians; it is a source of professional meaning and engagement for those who provide it.
On self-efficacy, measured by the General Self-Efficacy Scale (GSES), the relationship was inverse and moderate: higher perceived ability to manage professional challenges correlated meaningfully with lower burnout (rho = -0.49). This finding points toward psychological skill-building -clinical confidence, perceived competence, and the sense that one can effectively navigate difficult situations -as a modifiable burnout buffer.
What Doesn't Work: The Credentialing Myth
The study directly challenges a common institutional assumption: that continuing education, advanced certification, and professional organization membership reduce burnout. They do not. None of these variables showed a significant association with burnout scores. Terminal academic degrees (PhD/ScD/DSc/EdD) were associated with lower burnout, but the authors note this likely reflects role differences rather than the degree itself.
This has direct implications for clinical leaders designing wellness programs: investing in CE hours and certification pathways as a primary burnout mitigation strategy is not evidence-based. The evidence points elsewhere -to relational structures, perceived competence, and intentional mentorship infrastructure.
Building Mentorship at Scale: The Organizational Design Problem
Formal mentorship programs are not common in most PT practice settings. The profession has historically relied on informal, supervisory relationships -which are not equivalent to structured mentorship with dedicated time, matched pairings, clear goals, and institutional support. Health systems and large PT employers can build this infrastructure. They often choose not to because it is not directly reimbursable.
This is a false economy. The cost of turnover in PT -including recruitment, onboarding, productivity ramp, and cultural disruption -is substantially higher than the cost of a well-designed mentorship program. For post-acute settings in particular, where burnout and turnover are highest, the ROI on mentorship investment is arguably more compelling than in any other clinical domain.
The Takeaway
Burnout in the PT workforce is not primarily a pandemic artifact or an individual resilience failure. It is a structural product of work environments that lack relational infrastructure, perceived professional support, and formal mentorship. The evidence is specific enough to be actionable: health systems should audit their post-acute and home health PT environments for mentorship program existence and quality, build structured mentorship into residency and post-graduate programming, and measure self-efficacy as a workforce health indicator alongside traditional HR metrics.
For clinical leaders: if your organization is investing in PT certification pathways as a retention strategy without pairing them with mentorship structures, you may be spending in the wrong place.
🔥 Burnout affects half of U.S. PTs -49.34% report burnout -at rates comparable to pre-pandemic levels, signaling structural rather than situational drivers.
🤝 Mentorship is the most actionable lever -Formal mentorship given or received is consistently associated with meaningfully lower burnout scores.
💪 Self-efficacy buffers burnout -A moderate inverse correlation (rho = -0.49) between perceived competence and burnout highlights psychological skill-building as a target.
🏥 Post-acute settings are the red zone -Home health and SNF settings show the highest burnout -the same settings most critical to post-acute recovery outcomes.
🎓 CE and certification do not protect -Continuing education hours, advanced certifications, and organization memberships show no significant burnout association.
Pugliese, M., Brismée, J-M., Allen, B., Riley, S., Tammany, J., & Mintken, P. (2023). Mentorship and self-efficacy are associated with lower burnout in physical therapists in the United States: A cross-sectional survey study. Journal of Educational Evaluation for Health Professions, 20, 27. https://doi.org/10.3352/jeehp.2023.20.27
THURSDAY
659% Growth by 2060: The Arthroplasty Surge and What It Demands from Rehabilitation
For: Health System Executives | Orthopedic Service Line Leaders | Post-Acute Network Planners | Payers | PT Workforce Planners
Total Joint Replacement Is About to Become the Defining Volume Driver of Musculoskeletal Care
Health system leaders who are planning orthopedic service lines, post-acute networks, and rehabilitation capacity need to internalize one number from a 2023 study in JBJS Open Access: by 2060, combined Medicare total joint arthroplasty volume is projected to reach approximately 4.9 million procedures annually. That represents a 559% increase from 2019 levels. And because the study includes only Medicare patients 65 and older, the true national demand -including younger, commercially insured, and Medicaid populations undergoing joint replacement at increasing rates -will be higher still.
This is not a speculative projection. The underlying growth trend has been well-documented for two decades. Shichman and colleagues apply updated log-linear regression models to Medicare data from 2000 to 2019 and produce revised, methodologically careful projections that correct prior overestimates while confirming the fundamental trajectory: this wave is coming, and the health system's current rehabilitation infrastructure is not designed to absorb it.
"Understanding this trajectory is essential for preparing the health-care field for the case volume and financial challenges associated with these procedures." -Shichman et al., 2023, JBJS Open Access
The Projection Data: What the Numbers Actually Mean
Current Growth Rates
Using the 2000-2019 Medicare dataset, the authors calculate updated annual growth rates: 5.2% for total hip arthroplasty and 4.44% for total knee arthroplasty (TKA). These rates are lower than older projections from Kurtz and colleagues, which the authors attribute to improvements in implant longevity, infection control, and the slowing of early-adopter growth. The updated rates produce more conservative but, the authors argue, more credible projections.
THA annual growth rate: 5.2% (2000-2019 Medicare data) | TKA by 2040: ~1.2 million procedures (+139% from 2019) |
TKA annual growth rate: 4.44% | THA by 2060: ~1.98 million procedures (+659% from 2019) |
THA by 2040: ~719,000 procedures (+176% from 2019) | Combined TJA by 2060: ~4.9 million (+559% from 2019) |
The Hip-Knee Shift
One underappreciated projection: THA is growing faster than TKA, increasing its share of total joint arthroplasty from 35% in 2019 to a projected 40% by 2060. This reflects a convergence of factors -improving outcomes data, expanding indications, declining average patient age at surgery, and a growing body of evidence supporting hip arthroplasty for patients who previously would have been managed conservatively. For service line planners, this shift has implications for implant inventory, surgical scheduling, and post-acute rehabilitation protocol design.
The Undercount Problem
The study's authors are explicit about what the projections do not include: Medicare patients under 65 are excluded by design, and non-Medicare-insured patients are not captured. The authors state plainly: "These numbers certainly underestimate the true increase… our data inputs did not include patients <65 years of age and non-Medicare-insured patients." As arthroplasty age thresholds continue to decline and commercial payers expand coverage for younger patients with severe osteoarthritis, the gap between the Medicare-only projection and national demand will widen. Health system leaders should treat the 4.9 million figure as a floor, not a ceiling.
The Rehabilitation Demand Consequence
Physical Therapy Is the Critical Path -at Scale
Every total joint replacement produces a rehabilitation patient. The evidence base for structured PT after TKA and THA -for functional recovery, patient satisfaction, and avoidance of reoperation -is well established. The question is not whether these patients need rehabilitation; it is whether the health system can deliver it at the volume projected.
Consider the arithmetic: if TJA volume approaches 4.9 million procedures annually by 2060, and each patient requires 8-12 weeks of postoperative PT involving multiple visits per week, the aggregate demand for PT episodes represents one of the largest expansion events in the history of the profession. The current capacity -in terms of both PT workforce numbers and clinic infrastructure -is not on a trajectory to meet it.
Set this against Tuesday's finding that nearly half of PT clinics do not accept Medicaid, the post-acute SNF and home health settings burning through their workforce fastest (Wednesday), and the broader access equity gaps in the system -and the picture is uncomfortable. The arthroplasty surge is coming for a rehabilitation system that is simultaneously under-built, inequitably distributed, and losing its workforce to burnout.
The Value-Based Care Lever
Health systems operating under bundled payment models for total joints -including CMS Comprehensive Care for Joint Replacement (CJR) and successor models -are already managing post-acute PT utilization as a financial variable. Under risk-sharing models, unnecessary inpatient rehabilitation stays, extended SNF admissions, and excess visit utilization are cost problems. But inadequate PT leading to reoperation, stiffness, or falls is a larger cost problem.
The financially optimal path -and the clinically appropriate one -is structured outpatient or home-based PT with outcome measurement. Building the capacity to deliver that at scale, equitably, across Medicaid and Medicare populations alike, is the infrastructure challenge the arthroplasty projections make unavoidable.
The Takeaway
The 4.9 million projection is not a distant abstraction. The growth is already underway: THA volume increased 177% and TKA 156% between 2000 and 2019. Health systems that wait until 2035 to build post-acute rehabilitation capacity for this volume will have already lost the window. The strategic decisions -network design, workforce pipeline, value-based contracting, digital rehab infrastructure -need to be made now, in light of where the demand is going.
For PT service line leaders: what is your organization's plan to absorb 5-6% annual arthroplasty growth over the next decade while maintaining quality, access, and financial sustainability? If there is no plan, this study is the argument for building one.
📈 659% growth in hip arthroplasty by 2060 -THA volume is projected to reach ~1.98 million Medicare procedures annually; TKA ~2.9 million -a combined 559% increase from 2019.
🦵 THA gaining share -Hip arthroplasty will grow from 35% to 40% of total TJA volume by 2060, reflecting expanding indications and younger patient age at surgery.
🏥 Rehabilitation infrastructure is the critical path -Every joint replacement generates a PT patient; current rehab capacity is not on trajectory to absorb projected volume.
📊 Updated models correct prior overestimates -5.2% (THA) and 4.44% (TKA) annual growth rates produce more credible projections than older models.
⚠️ True demand is higher than projected -Medicare-only projections exclude patients under 65 and commercially insured populations -making 4.9 million a floor, not a ceiling.
Shichman, I., Roof, M., Askew, N., Nherera, L., Rozell, J. C., Seyler, T. M., & Schwarzkopf, R. (2023). Projections and epidemiology of primary hip and knee arthroplasty in Medicare patients to 2040–2060. JBJS Open Access, 8(3), e22.00112. https://doi.org/10.2106/JBJS.OA.22.00112
FRIDAY
16.9 Million Survivors -and a Care System That Doesn't Know What to Do With Them
For: Oncology Leaders | Rehabilitation Clinicians | Health System Executives | Value-Based Care Leaders | Payers
Cancer Survivorship Is a Mass Public Health Event
There are 16.9 million cancer survivors in the United States today, with a 5-year relative survival rate of 68% across all cancer types. Advances in early detection, surgical technique, systemic therapy, and radiation have transformed many cancers from acute illnesses into chronic, manageable conditions. The clinical challenge has shifted -from survival to survivorship, from treatment to long-term management of sequelae, recurrence risk, and quality of life.
And the evidence is clear that what happens after treatment ends matters enormously. A 2022 update to the American Cancer Society's Nutrition and Physical Activity Guideline for Cancer Survivors -published in CA: A Cancer Journal for Clinicians and drawing on systematic reviews, meta-analyses, pooled cohort analyses, and large RCTs produced since 2012 -makes the case with precision: modifiable lifestyle factors including diet, physical activity, adiposity, and alcohol intake are associated with recurrence, cancer-specific mortality, and overall survival. These factors are actionable. Most health systems are not yet acting on them systematically.
"The body of evidence… has increased substantially since the last version, especially in the form of systematic literature reviews and meta-analyses." -Rock et al., 2022, CA: A Cancer Journal for Clinicians
The Evidence: Lifestyle Factors Are Not Peripheral -They Are Prognostic
Physical Activity: The Most Robust Signal
The guideline synthesizes a substantial body of evidence establishing that exercise during and after cancer treatment is safe and beneficial. The authors state that "there is sufficient evidence that exercise during cancer treatment is beneficial in managing several aspects of quality of life." Documented benefits include reduced anxiety and depression, improved physical function, reduced lymphedema risk, better treatment tolerance in some populations, and emerging evidence for reduced recurrence risk in select cancer types.
The recommended modalities are familiar to rehabilitation clinicians: aerobic exercise, resistance training, and combined programs -the same evidence base PT practitioners apply in MSK rehabilitation. The clinical translation gap is structural: oncology care teams often do not refer to rehabilitation early or consistently, and PT and exercise oncology remain underutilized resources within most cancer center care models.
Nutrition and Weight: The Dual Risk
The guideline addresses two distinct nutritional domains with separate evidence bases. During active treatment, the primary concern is nutritional adequacy: malnutrition is common and associated with worse clinical outcomes. The authors specify that "the inability to maintain adequate nutritional status… is common and can negatively impact overall clinical outcomes," and call for systematic malnutrition screening, nutrition-focused physical assessment, and medical nutrition therapy coordinated with oncology dietitians.
Post-treatment, the evidence base shifts to adiposity as a risk factor for recurrence and mortality across multiple cancer types, independent of treatment effects. Achieving and maintaining healthy weight, reducing ultra-processed food intake, and following plant-forward dietary patterns are all associated with improved outcomes. This is not dietary preference guidance -it is evidence-based oncology.
Alcohol: A Modifiable Risk That Remains Underaddressed
The guideline is explicit: alcohol intake should be limited, and the evidence links consumption to poorer outcomes in multiple cancers. This recommendation is frequently absent from survivorship care plans and post-treatment oncology visits. It represents a low-cost, high-impact counseling opportunity that is systematically underutilized in most health system survivorship programs.
The Structural Barriers: Why the Guideline Isn't Reaching Patients
The authors do not let health systems off the hook. The guideline explicitly acknowledges: "Many cancer survivors face environmental, social, and structural barriers… including disparities in cancer care, food insecurity, targeted marketing, and lack of access to healthy food and opportunities to be physically active." This framing situates the evidence within the same access and equity context that has threaded through the week's other entries.
The barriers to lifestyle modification in cancer survivorship mirror those in MSK rehabilitation: insurance coverage limitations, geographic access gaps, reimbursement architecture that does not reward prevention, and a clinical culture that treats lifestyle counseling as a soft add-on rather than a clinical protocol. The guideline is evidence-based. The delivery infrastructure is not aligned with it.
16.9 million cancer survivors in the U.S. today | Exercise: safe and beneficial during treatment for most patients |
68% five-year relative survival rate across all cancer types | <3% of eligible patients receive documented lifestyle intervention |
Evidence base: systematic reviews and meta-analyses since 2012 | Adiposity linked to recurrence and mortality across multiple cancer types |
The Rehabilitation Profession's Role in Survivorship Care
Physical therapists, occupational therapists, and certified exercise physiologists are positioned to deliver the majority of what this guideline recommends -structured aerobic and resistance exercise, functional assessment, lymphedema management, nutritional coordination, and lifestyle counseling. Yet most cancer centers do not integrate these providers into survivorship care pathways in a systematic, protocol-driven way.
The exercise oncology subspecialty is growing, but remains a fraction of what the guideline's evidence base demands. Health systems building comprehensive cancer survivorship programs -particularly those pursuing ASCO Quality Oncology Practice Initiative (QOPI) certification or similar quality frameworks -have a clinical mandate and a reimbursement case for integrating rehabilitation professionals into survivorship care teams.
Summary and Community Impact
This week's five entries, taken together, map the shape of a profession -and a health system -that is simultaneously expanding in clinical evidence and contracting in delivery capacity. Physical therapy is needed more urgently than ever: by cancer survivors, by postoperative joint replacement patients, by pelvic floor disorder patients, by the 1 in 3 people worldwide who need rehabilitation and cannot access it. And yet the workforce is burned out, access is inequitably distributed by insurance type and geography, and the delivery infrastructure is not scaling at the rate the evidence demands.
The community-level impact of these gaps is not abstract. It is the Medicaid patient after rotator cuff repair who cannot find a clinic within a reasonable drive. It is the cancer survivor who receives a survivorship care plan with exercise recommendations and no referral to anyone qualified to implement them. It is the home health PT providing complex post-acute care in isolation, without mentorship or peer support, until she exits the profession. It is the rural patient who needs pelvic floor rehabilitation and has no access to a PT who can deliver it.
The evidence this week is not pessimistic -it is directional. Mentorship works. Digital health scales. Population health frameworks exist. The arthroplasty demand is foreseeable. The cancer survivorship guidelines are published. The question is whether health system leaders, payers, educators, and policymakers will treat these research signals as the operational mandates they are -or continue to absorb them as interesting reading.
The profession has the science. The community is waiting for the delivery.
🥗 Lifestyle as oncology management -Diet, physical activity, adiposity, and alcohol intake are all associated with recurrence risk and survival outcomes in cancer survivors.
🏃 Exercise is safe during treatment -Aerobic and resistance training improve quality of life, physical function, and treatment tolerance across cancer types.
⚖️ Adiposity is a modifiable risk factor -Weight management post-treatment influences recurrence and mortality across multiple cancer diagnoses -making it a clinical priority, not a lifestyle preference.
🍷 Alcohol is underaddressed -Evidence links consumption to worse outcomes in several cancers; alcohol counseling in survivorship visits remains systematically underutilized.
🌍 Structural barriers drive the gap -Food insecurity, access disparities, and inadequate insurance coverage prevent most survivors from acting on evidence-based lifestyle recommendations.
Rock, C. L., Thomson, C. A., Sullivan, K. R., Howe, C. L., Kushi, L. H., Caan, B. J., Neuhouser, M. L., Bandera, E. V., Wang, Y., Robien, K., Basen-Engquist, K. M., Brown, J. C., Courneya, K. S., Crane, T. E., Garcia, D. O., Grant, B. L., Hamilton, K. K., Hartman, S. J., Kenfield, S. A., … Mccullough, M. L. (2022). American Cancer Society nutrition and physical activity guideline for cancer survivors. CA: A Cancer Journal for Clinicians, 72(3), 230–262. https://doi.org/10.3322/caac.21719